metaproterenol has been researched along with Drug Withdrawal Symptoms in 2 studies
Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Broadley, KJ | 1 |
Williams, RG | 1 |
Hawthorn, MH | 1 |
Grassby, PF | 1 |
Lenz, H | 1 |
1 review available for metaproterenol and Drug Withdrawal Symptoms
Article | Year |
---|---|
Mechanisms of cardiac supersensitivity to sympathomimetic amines.
Topics: Animals; Guinea Pigs; Heart; Humans; Hydroxydopamines; Isoproterenol; Metaproterenol; Oxidopamine; R | 1984 |
1 other study available for metaproterenol and Drug Withdrawal Symptoms
Article | Year |
---|---|
[Psychotic withdrawal syndrome after Urbason and Alupent].
Topics: Climacteric; Female; Humans; Menopause; Metaproterenol; Methylprednisolone; Middle Aged; Psychotic D | 1972 |